(Q39940683)

15 September 2017

Perspectives on the development of imatinib and the future of cancer research (English)

1 reference

15 September 2017

1 reference

1

1 reference

PubMed ID

19812576

15 September 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

15 September 2017

1 reference

15 September 2017

15

1 reference

15 September 2017

1149-1152

1 reference

15 September 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1009-1149

15 September 2017

0 references

cites work

15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM1009-1149

Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

21 January 2018

1 reference

12 December 2020

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

1 reference

12 December 2020

Major response to imatinib mesylate in KIT-mutated melanoma.

1 reference

12 December 2020

An integrated genomic analysis of human glioblastoma multiforme

1 reference

12 December 2020

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

1 reference

12 December 2020

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

12 December 2020

Commentary: practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology

1 reference

12 December 2020

Enhancing the efficacy of hormonal agents with selected targeted agents

1 reference

12 December 2020

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

1 reference

12 December 2020

Oncogenes, growth factors, and signal transduction

1 reference

12 December 2020

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

12 December 2020

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

12 December 2020

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

1 reference

12 December 2020

George Khoury (1943-1987).

1 reference

12 December 2020

Translation of the Philadelphia chromosome into therapy for CML.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM1009-1149

1 reference

15 September 2017

1 reference

PubMed ID

19812576